Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The study aims to asses the effects of micronized (MIC) and nanoparticulate (NANO)
transdermal hormone therapy (THT) on blood pressure, ultra-sensitive C-reactive protein
(CRP), and cardiovascular risk factors in postmenopausal women.
Phase:
Phase 2
Details
Lead Sponsor:
University Potiguar
Collaborators:
Federal University of São Paulo InBios International, Inc.